John Finazzo - INGEN TECHNOLOGIES Director

IGNT -- USA Stock  

USD 0.0001  0.0001  50.00%

Dr. John Finazzo, M.D., is a Director of Ingen Technologies, Inc. He is graduated from the University of California, Riverside in 1986 with a degree in BioMedical Sciences. He received his MD degree from the UCLA School of Medicine in 1989. He completed a twoyear Surgical Internship at UCLA Center for Health Science in 1991. He then completed residency in Otolaryngology Head and Neck Surgery at the State University of New York Health Science Center, Brooklyn in 1995. He is Board Certified in Otolaryngology . Dr. Finazzo was in private practice in the Palm Springs area for eight years. He is also on the surgical staffs at the Desert Regional Medical Center, the John F. Kennedy Medical Center and the Eisenhower Medical Center. Dr. Finazzo is also Section Chief Division of Otolaryngology at Eisenhower Medical Center. He resides in Palm Springs with his wife of 15 years. He is active in clinical research for the treatment of acute sinusitis.
Age: 44  Director Since 2006      

Management Efficiency

The company has return on total asset (ROA) of (2.02) % which means that it has lost $2.02 on every $100 spent on asset. This is way below average.
The company currently holds 4.76 M in liabilities. INGEN TECHNOLOGIES INC has Current Ratio of 0.03 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.

Entity Summary

Ingen Technologies, Inc., a medical device manufacturing company, manufactures medical products for the respiratory industry in United States. Ingen Technologies, Inc. was founded in 1999 and is based in Riverside, California. INGEN TECHNOLOGIES operates under Medical Devices classification in USA and is traded on BATS Exchange.INGEN TECHNOLOGIES INC [IGNT] is traded as part of a regulated electronic over-the-counter service offered by the NASD.


Christopher Wirth, Director
Stephen OHara, Director
John Finazzo, Director
Yong Khoo, Director
Thomas Neavitt, Interim CEO, CFO, Principal Accounting Officer, Controller and Director